Neochem Bio Solutions Key Ratios
NSE: NEOCHEM
₹108.40
₹7.40
(7.33%)
As on 27-Oct-2026IST
Market cap
₹186 Cr
Revenue (TTM)
₹111 Cr
P/E Ratio
15.4
P/B Ratio
2.4
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | 31.51 | 31.95 | -- |
| EBIT | -- | -- | 62.16 | 82.19 | -- |
| Net Profit | -- | -- | 61.64 | 119.28 | -- |
| EPS | -- | -- | 10.29 | 80.15 | -- |
| Book Value | -- | -- | 172.34 | 73.40 | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Mar-26 | Mar-25 | Mar-24 |
| EBIT-Margin
| 12.82 | -- | 16.81 | 13.63 | 8.02 |
| Net Margin
| 7.45 | -- | 10.61 | 8.64 | 3.11 |
| Return on equity
| 29.81 | -- | 24.40 | 46.41 | 18.62 |
| Return on Capital
| 22.75 | -- | 27.22 | 26.64 | 14.38 |
| Return on Assets
| 8.70 | -- | 12.27 | 10.45 | 3.38 |
| Debt to Equity (x)
| -- | -- | 0.23 | 1.80 | 2.71 |
Profitability
ROCE
27.22
Higher than Peers by 12.62
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Neochem Bio Solutions
|
27.22
|
26.64
|
14.38
|
11.89
|
9.38
|
|
Peer Median
|
14.59
|
9.88
|
12.69
|
20.70
|
--
|
ROE
24.40
Higher than Peers by 11.75
Profit after tax / Average Net worth * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Neochem Bio Solutions
|
24.40
|
46.41
|
18.62
|
18.28
|
23.73
|
|
Peer Median
|
12.65
|
7.42
|
10.08
|
19.72
|
--
|
ROA
12.27
Higher than Peers by 3.63
Profit after tax / Average Total assets * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Neochem Bio Solutions
|
12.27
|
10.45
|
3.38
|
2.35
|
2.09
|
|
Peer Median
|
8.64
|
4.26
|
3.39
|
7.22
|
--
|
EBIT Margin
16.81
Higher than Peers by 7.08
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Neochem Bio Solutions
|
16.81
|
13.63
|
8.02
|
6.38
|
5.09
|
|
Peer Median
|
9.73
|
4.19
|
7.38
|
9.34
|
--
|
Net Margin
10.61
Higher than Peers by 2.04
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Neochem Bio Solutions
|
10.61
|
8.64
|
3.11
|
2.34
|
1.99
|
|
Peer Median
|
8.56
|
3.51
|
3.20
|
7.33
|
--
|
Cash Profit Margin
11.99
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Neochem Bio Solutions
|
11.99
|
10.42
|
5.15
|
4.89
|
4.14
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
31.51
Lower than Peers by 68.79
Year on year growth in net sales
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Neochem Bio Solutions
|
31.51
|
37.66
|
26.89
|
-0.84
|
--
|
|
Peer Median
|
100.31
|
7.64
|
29.09
|
31.46
|
--
|
EBIT Growth
62.16
Higher than Peers by 15.55
Year on year growth in operating profit (EBIT)
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Neochem Bio Solutions
|
62.16
|
134.03
|
59.36
|
24.47
|
--
|
|
Peer Median
|
46.61
|
21.70
|
81.59
|
19.00
|
--
|
Net Profit Growth
61.64
Lower than Peers by 23.31
Year on year growth in profit after tax
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Neochem Bio Solutions
|
61.64
|
286.10
|
68.94
|
17.45
|
--
|
|
Peer Median
|
84.95
|
-11.10
|
106.26
|
41.20
|
--
|
EPS Growth
10.29
Lower than Peers by 74.66
Year on year growth in earnings per share
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Neochem Bio Solutions
|
10.29
|
286.09
|
37.30
|
-35.05
|
--
|
|
Peer Median
|
84.95
|
-32.27
|
--
|
102.60
|
--
|
Book Value Growth
299.16
--
Year on year growth in book value per share
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Neochem Bio Solutions
|
299.16
|
60.43
|
46.83
|
104.91
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.23
Lower than Peers by 0.09
Total debt / Net worth
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Neochem Bio Solutions
|
0.23
|
1.80
|
2.71
|
3.12
|
5.69
|
|
Peer Median
|
0.31
|
0.70
|
0.81
|
0.82
|
--
|
Short term debt to equity ratio
0.22
--
(Short term borrowings / Net worth)
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Neochem Bio Solutions
|
0.22
|
1.01
|
1.13
|
1.35
|
1.42
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
2.39
Higher than Peers by 0.79
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Neochem Bio Solutions
|
2.39
|
1.21
|
1.16
|
1.09
|
1.10
|
|
Peer Median
|
1.61
|
1.02
|
1.32
|
1.33
|
--
|
Quick Ratio
1.58
Lower than Peers by 0.32
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Neochem Bio Solutions
|
1.58
|
0.67
|
0.60
|
0.57
|
0.60
|
|
Peer Median
|
1.90
|
1.24
|
0.57
|
0.59
|
--
|
Interest Coverage
5.90
Higher than Peers by 1.18
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Neochem Bio Solutions
|
5.90
|
3.84
|
1.95
|
1.76
|
2.00
|
|
Peer Median
|
4.72
|
2.05
|
1.93
|
3.69
|
--
|
Operating Efficiency
Debtors to sales
44.01
Higher than Peers by 17.23
Debtors outstanding / Net Sales * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Neochem Bio Solutions
|
44.01
|
30.03
|
27.37
|
29.39
|
28.05
|
|
Peer Median
|
26.78
|
10.72
|
14.68
|
6.56
|
--
|
Asset Turnover
1.13
Lower than Peers by 5.67
Sales / Average Total Assets
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Neochem Bio Solutions
|
1.13
|
1.18
|
1.07
|
0.99
|
1.05
|
|
Peer Median
|
6.80
|
1.35
|
1.28
|
1.50
|
--
|
Receivable days
122.00
--
Average Debtors / Sales * 365
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Neochem Bio Solutions
|
122.00
|
91.10
|
92.22
|
105.25
|
102.37
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
87.39
--
Average Inventory / Sales * 365
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Neochem Bio Solutions
|
87.39
|
90.99
|
98.91
|
106.89
|
99.85
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
69.00
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Neochem Bio Solutions
|
69.00
|
101.95
|
130.21
|
179.10
|
185.98
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
140.39
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Neochem Bio Solutions
|
140.39
|
80.14
|
60.92
|
33.04
|
16.24
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
9.00
Lower than Peers by 7.43
Current share price divided by earning per share in the last twelve months
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Neochem Bio Solutions
|
9.00
|
--
|
--
|
--
|
--
|
|
Peer Median
|
16.43
|
26.26
|
17.22
|
12.36
|
--
|
Price / Book Value
1.37
Lower than Peers by 0.89
Current share price divided by book value per share in the latest financial year
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Neochem Bio Solutions
|
1.37
|
--
|
--
|
--
|
--
|
|
Peer Median
|
2.26
|
0.85
|
1.07
|
0.87
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Neochem Bio Solutions
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
5.58
Lower than Peers by 5.34
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Neochem Bio Solutions
|
5.58
|
2.86
|
5.68
|
6.44
|
7.18
|
|
Peer Median
|
10.92
|
13.35
|
6.29
|
3.30
|
--
|
Market Cap
108
Lower than Peers by 77
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Neochem Bio Solutions
|
108
|
--
|
--
|
--
|
--
|
|
Peer Median
|
186
|
89
|
79
|
141
|
--
|
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
